Life-threatening complications and intensive care unit management in patients treated with blinatumomab for B-cell acute lymphoblastic leukemia

Crit Care. 2024 Jan 5;28(1):14. doi: 10.1186/s13054-023-04787-x.

Irene Urbino^#^{1

2}, Etienne Lengliné^#³, Sandrine Valade⁴, Marco Cerrano^{3

5}, Marie Sebert³, Emmanuel Raffoux³, Florence Rabian³, Elie Azoulay⁴, Nicolas Boissel⁶

¹ Hématologie Clinique, Hôpital Saint-Louis, APHP, Université Paris Diderot, Paris, France. urbinoirene@gmail.com.
² Division of Hematology, Department of Oncology, AOU Città della Salute e della Scienza di Torino, Turin, Italy. urbinoirene@gmail.com.
³ Hématologie Clinique, Hôpital Saint-Louis, APHP, Université Paris Diderot, Paris, France.
⁴ Medical Intensive Care Unit, Hôpital Saint-Louis, APHP, Université Paris Diderot, Paris, France.
⁵ Division of Hematology, Department of Oncology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
⁶ Hématologie Clinique, Hôpital Saint-Louis, APHP, Université Paris Diderot, Paris, France. nicolas.boissel@aphp.fr.

^# Contributed equally.

No abstract available

Publication types